Sinovac Biotech, Ltd. Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (16)

Latest Posts

About This Stock More About This Stock
Week In Review: Suzhou Innovent Files For HK IPO -- $500 Million Raise Rumored
Article By: ChinaBio® Today
Saturday, July 7, 2018 4:06 PM EDT
Innovent Biologics of Suzhou has filed to IPO on the Hong Kong Exchange under its new rules for pre-revenue biopharmas. The company plans to raise as much as $500 million, according to media reports, at a valuation of over $1 billion.
In this article: LLY, SNY, SVA, BABA, ATNX
Read
Week In Review: Another Billion Dollar Week For China Life Science Deals
Article By: ChinaBio® Today
Saturday, September 30, 2017 5:55 PM EDT
Shanghai Pharma Holding (SHA: 601607) may acquire part of Alvogen -- possibly Alvogen's US operations -- according to Bloomberg. Alvogen is a US-based generic drug maker thought to be worth as much as $4 billion.
In this article: NVO, SNY, SVA, AMGN, GILD, ZLAB, TSRO
Read
Week In Review: Sinovac's Privatization Offer Draws $459 Million Outside Bid
Article By: ChinaBio® Today
Saturday, July 1, 2017 7:14 PM EDT
Shandong Sinobioway Biomedicine topped management's $402 million bid to privatize China vaccine maker Sinovac with a $459 million offer of its own. Sinovac is a Beijing vaccine company with legacy vaccines for hepatitis A and B.
In this article: AZN, GE, SVA, HCM
Read
Week In Review: Beijing's Berry Genomics Valued At $619 Million In Reverse Merger
Article By: ChinaBio® Today
Saturday, December 24, 2016 4:36 PM EDT
Berry Genomics, a Beijing genetic testing company, will IPO via a reverse merger with Chengdu Tianxing Instrument & Meter (SHZ: 0710) at a valuation of $619 million on China's Shenzhen market.
In this article: SVA, BGNE
Read
Week In Review: New Deals Fund China Life Science Innovation
Article By: ChinaBio® Today
Saturday, September 3, 2016 1:30 PM EDT
Beijing Allcure Medical Technology, a radiology oncology startup developing big data/cloud computing applications, raised $27 million in an A+ funding round.
In this article: CCM, SVA
Read

PARTNER HEADLINES

Latest Tweets for $SVA

No tweets yet!